{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T12:10:13Z","timestamp":1772539813645,"version":"3.50.1"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2011,8,2]],"date-time":"2011-08-02T00:00:00Z","timestamp":1312243200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1007\/s00431-011-1540-4","type":"journal-article","created":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T05:25:18Z","timestamp":1312176318000},"page":"1471-1474","source":"Crossref","is-referenced-by-count":131,"title":["Omalizumab in the treatment of eosinophilic esophagitis and food allergy"],"prefix":"10.1007","volume":"170","author":[{"given":"Ruben","family":"Rocha","sequence":"first","affiliation":[]},{"given":"Artur Bonito","family":"Vitor","sequence":"additional","affiliation":[]},{"given":"Eunice","family":"Trindade","sequence":"additional","affiliation":[]},{"given":"Rosa","family":"Lima","sequence":"additional","affiliation":[]},{"given":"Marta","family":"Tavares","sequence":"additional","affiliation":[]},{"given":"Joanne","family":"Lopes","sequence":"additional","affiliation":[]},{"given":"Jorge Amil","family":"Dias","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2011,8,2]]},"reference":[{"key":"1540_CR1","unstructured":"Alpan O (2009) Identifying responders to Xolair (omalizumab) using eosinophilic esophagitis as a disease model. ClinicalTrials.gov identifier: NCT01040598. Available via http:\/\/clinicaltrials.gov . Accessed 2 April 2011"},{"key":"1540_CR2","unstructured":"Fang JC (2005) A pilot study of the treatment of eosinophilic esophagitis with omalizumab. ClinicalTrials.gov identifier: NCT00123630. Available via http:\/\/clinicaltrials.gov . Accessed 2 April 2011"},{"issue":"5","key":"1540_CR3","first-page":"155","volume":"41","author":"F Menzella","year":"2009","unstructured":"Menzella F, Facciolongo N, Castagnetti C, Simonazzi A, Zucchi L (2009) Omalizumab: when the non-responder is a late-responder. Eur Ann Allergy Clin Immunol 41(5):155\u20139","journal-title":"Eur Ann Allergy Clin Immunol"},{"issue":"1","key":"1540_CR4","doi-asserted-by":"crossref","first-page":"76","DOI":"10.2500\/aap.2010.31.3304","volume":"31","author":"A Rafi","year":"2010","unstructured":"Rafi A, Do LT, Katz R, Sheinkopf LE, Simons CW, Klaustermeyer W (2010) Effects of omalizumab in patients with food allergy. Allergy Asthma Proc 31(1):76\u201383","journal-title":"Allergy Asthma Proc"},{"issue":"6","key":"1540_CR5","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.jaci.2006.09.007","volume":"118","author":"ML Stein","year":"2006","unstructured":"Stein ML, Collins MH, Villanueva JM, Kushner JP, Putnam PE, Buckmeier BK, Filipovich AH, Assa'ad AH, Rothenberg ME (2006) Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis. J Allergy Clin Immunol 118(6):1312\u20139","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"1540_CR6","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1111\/j.1365-2222.2008.03122.x","volume":"38","author":"KD Stone","year":"2008","unstructured":"Stone KD, Prussin C (2008) Immunomodulatory therapy of eosinophil-associated gastrointestinal diseases. Clin Exp Allergy 38(12):1858\u201365","journal-title":"Clin Exp Allergy"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-011-1540-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00431-011-1540-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-011-1540-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T22:22:12Z","timestamp":1559082132000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00431-011-1540-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,2]]},"references-count":6,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["1540"],"URL":"https:\/\/doi.org\/10.1007\/s00431-011-1540-4","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,2]]}}}